Editorial comment

J Urol. 2009 Nov;182(5):2272; discussion 2273. doi: 10.1016/j.juro.2009.07.159. Epub 2009 Sep 16.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Androgen Antagonists / adverse effects*
  • Complementary Therapies
  • Humans
  • Isoflavones / administration & dosage*
  • Isoflavones / therapeutic use
  • Male
  • Prostatic Neoplasms / drug therapy*

Substances

  • Androgen Antagonists
  • Isoflavones